MARATTO

article · Experimental Cell Research

Engineered exosomes for CRISPR/Cas delivery to overcome oncogene-driven drug resistance

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Extracellular vesicles in disease
  • CRISPR and Genetic Engineering
  • RNA Interference and Gene Delivery

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.yexcr.2026.115159

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.